Filtersets and Catheters for Acute Therapy

Vantive offers a range of filtersets and catheters to meet the needs of critically ill patients.

Enabling multiple therapies

Our various filtersets and catheters enable clinicians to use a single acute therapy system to deliver therapies that manage acute renal failure, fluid overload, drug overdose and poisoning, and other diseases where the removal of plasma components is indicated. Using the filtersets to administer these therapies, a single system can perform continuous renal replacement therapy, therapeutic plasma exchange and liver detoxification.

Clinician stands at the bedside in front of the PrisMax System

CRRT Filtersets

Biocompatible AN69 CRRT filtersets, with an adsorptive clearance mechanism, can be used with all CRRT modalities and can support modality change during treatment.

PrismaLung+ Blood Gas Exchanger

The PrismaLung+ blood-gas exchanger enables standalone ECCO₂R therapy or ECCO₂R in combination with CRRT.¹

Oxiris Set

Oxiris is the only 3-in-1 blood purification filterset to effectively remove inflammatory mediators such as cytokines and endotoxins as a blood purification therapy for sepsis management. Therapy can be delivered as a stand alone hemoprofusion treatment or while delivering CRRT.^2-6

TPE Filtration Sets

The TPE filterset enables removal of plasma containing abnormal large molecular weight substances and simultaneous infusion of a replacement solution.

GamCath Catheters

The line of GamCath catheters includes Conventional, HighFlow, and Dolphin Protect Coating options to meet the needs of adult and pediatric patients in the ICU.

Molecular Adsorbent Recirculating System (MARS)

The MARS filterset enables the removal of harmful drugs and poisons in combination with CRRT.

Important Safety Information

Please click here for important safety information.

Vantive, AN69, GamCath, MARS, Oxiris, Prismaflex, PrismaLung+, Prismax and TrueVue are trademarks of Vantive Health LLC or its affiliates.

References

Vantive Health LLC. PrismaLung+ Instructions for Use. May 2021.
Turani F, Barchetta R, Falco M, Busatti S, Weltert L. Continuous renal replacement therapy with the adsorbing filter Oxiris in septic patients: a case series. Blood Purif. 2019;47(3):54-58.
Villa G, Romagnoli S, De Rosa S, et al. Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID-19: a pilot study. Crit Care. 2020;24:605.
Broman ME, Hansson F, Vincent JL, Bodelsson M. Endotoxin and cytokine reducing properties of the Oxiris membrane in patients with septic shock: a randomized crossover double-blind study. PLoS One. 2019;14:e0220444.
Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp. 2018;6:12.
Vantive Health LLC. Oxiris Instructions for Use. 2022.